| 51 |
24282104 | Effects of switching from insulin glargine or detemir to insulin degludec in patients with type 1 diabetes mellitus. | 2013 Dec |
1 |
| 52 |
24499517 | Initiation of once daily insulin detemir is not associated with weight gain in patients with type 2 diabetes mellitus: results from an observational study. | 2013 Oct 2 |
1 |
| 53 |
22218757 | Strategies for insulin initiation: insights from the French LIGHT observational study. | 2012 Jan |
1 |
| 54 |
22261942 | Hypertriglyceridemia-induced acute pancreatitis treated with insulin and heparin. | 2012 Feb 1 |
1 |
| 55 |
22291472 | Insulin detemir for the treatment of obese patients with type 2 diabetes. | 2012 |
3 |
| 56 |
22590494 | Molecular characterisation of long-acting insulin analogues in comparison with human insulin, IGF-1 and insulin X10. | 2012 |
1 |
| 57 |
22870179 | Insulin analogue levemir and development of pancreatic adenocarcinoma: a case report and literature review. | 2012 Aug |
2 |
| 58 |
23110609 | Insulin detemir: a review of its use in the management of diabetes mellitus. | 2012 Dec 3 |
6 |
| 59 |
23148201 | Efficacy and safety of insulin lispro protamine suspension as basal supplementation in patients with type 2 diabetes. | 2012 Jun |
1 |
| 60 |
20570843 | Lipoatrophy with insulin analogues in type I diabetes. | 2011 Jan |
2 |
| 61 |
21114606 | Co-administration of liraglutide with insulin detemir demonstrates additive pharmacodynamic effects with no pharmacokinetic interaction. | 2011 Jan |
1 |
| 62 |
21727749 | Diabetes and Ramadan: an update on use of glycemic therapies during fasting. | 2011 Jul-Aug |
1 |
| 63 |
21740289 | Adherence and persistence to a regimen of basal insulin in a pre-filled pen compared to vial/syringe in insulin-naïve patients with type 2 diabetes. | 2011 Sep |
3 |
| 64 |
22267935 | Pharmacokinetics and pharmacodynamics of insulin analogs in special populations with type 2 diabetes mellitus. | 2011 |
1 |
| 65 |
22287854 | Detemir as a once-daily basal insulin in type 2 diabetes. | 2011 |
3 |
| 66 |
23449422 | Insulin detemir attenuates food intake, body weight gain and fat mass gain in diet-induced obese Sprague-Dawley rats. | 2011 Jul 4 |
1 |
| 67 |
19919375 | Comparison of daily insulin dose and other antidiabetic medications usage for type 2 diabetes patients treated with an analog basal insulin. | 2010 Jan |
1 |
| 68 |
20199195 | Treatment with insulin glargine (Lantus) increases the proliferative potency of the serum of patients with type-1 diabetes: a pilot study on MCF-7 breast cancer cells. | 2010 May |
1 |
| 69 |
21055982 | Insulin glargine is more potent in activating the human IGF-I receptor than human insulin and insulin detemir. | 2010 Dec |
1 |
| 70 |
21701633 | Glargine and detemir: Safety and efficacy profiles of the long-acting basal insulin analogs. | 2010 |
1 |
| 71 |
19120431 | Insulin analogues: an example of applied medical science. | 2009 Jan |
1 |
| 72 |
19120433 | Once-daily insulin detemir is comparable to once-daily insulin glargine in providing glycaemic control over 24 h in patients with type 2 diabetes: a double-blind, randomized, crossover study. | 2009 Jan |
1 |
| 73 |
19193822 | Insulin analog therapy: improving the match with physiologic insulin secretion. | 2009 Jan |
2 |
| 74 |
19418931 | [Insulin detemir in the predictive study: results in patients with type 1 diabetes in the Belgian cohort]. | 2009 Mar |
4 |
| 75 |
19436668 | Changing basal insulin from NPH to detemir or glargine in patients with type 1 diabetes and a history of severe hypoglycemia. | 2009 |
3 |
| 76 |
19513632 | Effect of insulin detemir dose frequency on clinical outcomes in patients with diabetes in PREDICTIVE. | 2009 May |
1 |
| 77 |
19650876 | Insulin detemir causes increased symptom awareness during hypoglycaemia compared to human insulin. | 2009 Nov |
4 |
| 78 |
19707744 | Differential effects of insulin detemir and neutral protamine Hagedorn (NPH) insulin on hepatic glucose production and peripheral glucose uptake during hypoglycaemia in type 1 diabetes. | 2009 Nov |
1 |
| 79 |
19761358 | Pharmacokinetics and pharmacodynamics of insulin lispro protamine suspension compared with insulin glargine and insulin detemir in type 2 diabetes. | 2009 Nov |
1 |
| 80 |
19900235 | Plasma glucose and hypoglycaemia following exercise in people with Type 1 diabetes: a comparison of three basal insulins. | 2009 Oct |
1 |
| 81 |
19905891 | Rationale, design, and baseline data of the insulin glargine (Lantus) versus insulin detemir (Levemir) Treat-To-Target (L2T3) study: A multinational, randomized noninferiority trial of basal insulin initiation in type 2 diabetes. | 2009 Nov |
1 |
| 82 |
19922879 | Comparison of insulin detemir and insulin glargine in a basal-bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: a 52-week, multinational, randomized, open-label, parallel-group, treat-to-target noninferiority trial. | 2009 Oct |
1 |
| 83 |
18083783 | Different brain responses to hypoglycemia induced by equipotent doses of the long-acting insulin analog detemir and human regular insulin in humans. | 2008 Mar |
1 |
| 84 |
18227475 | Long-acting insulin analogs versus insulin pump therapy for the treatment of type 1 and type 2 diabetes. | 2008 Feb |
1 |
| 85 |
18414816 | Is the use of insulin analogues cost-effective? | 2008 Apr |
1 |
| 86 |
18465359 | Insulin, insulin analogues and diabetic retinopathy. | 2008 Feb |
4 |
| 87 |
18571747 | Effect of insulin detemir, compared to human insulin, on 3T3-L1 adipogenesis. | 2008 Nov 29 |
2 |
| 88 |
18585815 | Characteristics of signalling properties mediated by long-acting insulin analogue glargine and detemir in target cells of insulin. | 2008 Sep |
1 |
| 89 |
18594486 | How do detemir and glargine compare when added to oral agents in insulin-naïve patients with type 2 diabetes mellitus? | 2008 Sep |
1 |
| 90 |
18615401 | [New developments in the treatment and monitoring of type 1 diabetes mellitus]. | 2008 May-Jun |
2 |
| 91 |
18671472 | An update on the use of insulin detemir, with a focus on type 2 diabetes (drug evaluation update). | 2008 Aug |
1 |
| 92 |
18715209 | Beyond the era of NPH insulin--long-acting insulin analogs: chemistry, comparative pharmacology, and clinical application. | 2008 Oct |
1 |
| 93 |
18787302 | Pharmacological and clinical profiles of new soluble basal insulin analogue, Insulin Detemir (Levemir). | 2008 Sep |
2 |
| 94 |
19108786 | A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes. | 2008 Nov |
1 |
| 95 |
17300174 | Mass spectrometric identification of degradation products of insulin and its long-acting analogues in human urine for doping control purposes. | 2007 Mar 15 |
2 |
| 96 |
17565917 | Therapy conversion to insulin detemir among patients with type 2 diabetes treated with oral agents: a modeling study of cost-effectiveness in the United States. | 2007 Mar-Apr |
1 |
| 97 |
16554934 | [Insulin analogues: searching for a physiological replacement]. | 2006 Feb |
1 |
| 98 |
16736846 | [Insulin analogues: place of detemir (levemir)]. | 2006 Mar-Apr |
7 |
| 99 |
16841022 | Insulin detemir (levemir), a new long-acting insulin. | 2006 Jul 3 |
4 |
| 100 |
16866083 | [Insulin analogues: place of detemir (Levemir)]. | 2006 |
6 |